Table: Rohto -Q1 group results

Rohto Pharmaceutical

06/08/2026 07:33

    Aug 6 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               91.62               81.96           372.30    
                   (+11.8 pct)         (+19.9 pct)      (+8.3 pct)  
  Operating           13.66               11.70            45.00    
                   (+16.8 pct)         (-0.8 pct)       (+9.4 pct)  
  Recurring           14.49               16.13            47.40    
                   (-10.1 pct)         (+31.4 pct)      (-1.2 pct)  
  Net                 10.65               11.77            35.20    
                   (-9.5 pct)          (+38.7 pct)      (+2.8 pct)  
  EPS               47.14 yen           52.09 yen       155.78 yen  
  EPS Diluted       46.50 yen           51.39 yen                   
  Ann Div                               46.00 yen        50.00 yen  
  -Q2 div                               21.00 yen        25.00 yen  
  -Q4 div                               25.00 yen        25.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T